Center-Authored Papers

Filters: Author is van Besien, Koen  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2009
Loberiza FR, Lee SJ, Freytes CO, Giralt SA, van Besien K, Kurian S, del Cerro P, Toro JJ, Williams LA, Ketelsen SW et al..  2009.  Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(8):903-9. Abstract
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
2010
Bishop MR, Alyea EP, Cairo MS, Falkenburg FJH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D et al..  2010.  Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(5):563-4.
Porter DL, Alyea EP, Antin JH, DeLima M, Estey EH, Falkenburg FJH, Hardy N, Kroeger N, Leis J, Levine J et al..  2010.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(11):1467-503. Abstract
2011
Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers MED, Gupta V, Hsu JW, Jagasia M, Kitko CL, Maziarz RT et al..  2011.  Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(1):124-32. Abstract
Bishop MR, Alyea EP, Cairo MS, Falkenburg FJH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter DL et al..  2011.  National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(4):443-54. Abstract
Greinix HT, van Besien K, Elmaagacli AH, Hillen U, Grigg A, Knobler R, Parenti D, Reddy V, Theunissen K, Michallet M et al..  2011.  Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(12):1775-82. Abstract
2013
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Smith SM, Burns LJ, van Besien K, Le Rademacher J, He W, Fenske TS, Suzuki R, Hsu JW, Schouten HC, Hale GA et al..  2013.  Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(25):3100-9. Abstract
Acute Disease
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Adolescent
Smith SM, Burns LJ, van Besien K, Le Rademacher J, He W, Fenske TS, Suzuki R, Hsu JW, Schouten HC, Hale GA et al..  2013.  Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(25):3100-9. Abstract
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Adult
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Smith SM, Burns LJ, van Besien K, Le Rademacher J, He W, Fenske TS, Suzuki R, Hsu JW, Schouten HC, Hale GA et al..  2013.  Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(25):3100-9. Abstract
Antineoplastic Combined Chemotherapy Protocols
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Busulfan
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Cause of Death
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
Center-Authored Paper
Loberiza FR, Lee SJ, Freytes CO, Giralt SA, van Besien K, Kurian S, del Cerro P, Toro JJ, Williams LA, Ketelsen SW et al..  2009.  Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(8):903-9. Abstract
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers MED, Gupta V, Hsu JW, Jagasia M, Kitko CL, Maziarz RT et al..  2011.  Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(1):124-32. Abstract
Greinix HT, van Besien K, Elmaagacli AH, Hillen U, Grigg A, Knobler R, Parenti D, Reddy V, Theunissen K, Michallet M et al..  2011.  Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(12):1775-82. Abstract
Bishop MR, Alyea EP, Cairo MS, Falkenburg FJH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D et al..  2010.  Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(5):563-4.
Porter DL, Alyea EP, Antin JH, DeLima M, Estey EH, Falkenburg FJH, Hardy N, Kroeger N, Leis J, Levine J et al..  2010.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(11):1467-503. Abstract
Child
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Smith SM, Burns LJ, van Besien K, Le Rademacher J, He W, Fenske TS, Suzuki R, Hsu JW, Schouten HC, Hale GA et al..  2013.  Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(25):3100-9. Abstract